Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of SAP SE SAP rose sharply in today's pre-market trading after the company reported second-quarter financial results.

SAP reported quarterly earnings of 82 cents per share which missed the analyst consensus estimate of $1.19 per share. Quarterly sales came in at $8.92 billion which missed the analyst consensus estimate of $8.96 billion, representing an 8.81% increase over sales from the same period last year, according to data from Benzinga Pro.

SAP shares gained 5.9% to $212.34 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Nature’s Miracle Holding Inc. NMHI rose 183.4% to $0.9779 in pre-market trading after falling 13% on Monday.
  • Volato Group, Inc. SOAR gained 140.5% to $1.15 in pre-market trading after jumping around 20% on Monday.
  • Frequency Electronics, Inc. FEIM shares climbed 32% to $13.33 in pre-market trading following fourth-quarter earnings. Also, the company declared a $1.00 special cash dividend.
  • MSP Recovery, Inc. LIFW gained 24.6% to $0.6319 in pre-market trading after the company announced a settlement with another group of affiliated P&C insurers.
  • Mammoth Energy Services, Inc. TUSK shares gained 23.1% to $4.31 in pre-market trading after the company announced its subsidiary, Cobra Acquisitions, entered into a release and settlement agreement with the Puerto Rico Electric Power Authority.
  • MAIA Biotechnology, Inc. MAIA gained 22.9% to $4.61 in pre-market trading after reporting Phase 2 results for lung cancer treatment THIO.
  • Professional Diversity Network, Inc. IPDN shares gained 20.2% to $0.59 in pre-market trading.
  • New Horizon Aircraft Ltd. HOVR shares gained 13.5% to $0.6105 in pre-market trading after falling over 8% on Monday.
  • Mesoblast Limited MESO shares surged 12.5% to $8.50 in pre-market trading. Mesoblast recently started enrollment in Phase 3 trial of Rexlemestrocel-L for chronic low back pain.

Losers

  • TransCode Therapeutics, Inc. RNAZ shares fell 57.2% to $0.3395 in pre-market trading. TransCode Therapeutics priced its $3 million public offering of 10 million common shares at $0.30 per share.
  • MIRA Pharmaceuticals, Inc. MIRA shares fell 30.3% to $3.49 in pre-market trading. MIRA Pharmaceuticals shares jumped 627% on Monday after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.
  • CareMax, Inc. CMAX shares fell 25.3% to $3.87 in pre-market trading after surging 228% on Monday.
  • Nukkleus Inc. NUKK shares declined 21.5% to $0.3910 in pre-market trading after gaining over 55% on Monday.
  • Exicure, Inc. XCUR shares fell 17.5% to $0.41 in pre-market trading after declining around 7% on Monday.
  • Castellum, Inc. CTM fell 15% to $0.17 in pre-market trading. Castellum recently announced a new strategic alliance with Krilla Kaleiwahea.
  • Medpace Holdings, Inc. MEDP shares declined 12.6% to $382.00 in pre-market trading after the company reported mixed second-quarter financial results and narrowed its FY24 revenue guidance with its midpoint below estimates.
  • Netcapital Inc. NCPL fell 11.8% to $0.0989 in pre-market trading after gaining around 8% on Monday.
  • Stem, Inc. STEM shares dipped 11.4% to $1.17 in pre-market trading after gaining 7% on Monday.
  • NXP Semiconductors N.V. NXPI shares fell 9.1% to $258.03 in pre-market trading following mixed second-quarter earnings.

Now Read This:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!